Share
 
Title
Code
Session Type
Channel
Date Time
Chair:
15:00
HY01.01LB
VRC01 antibody prevention of HIV
Lawrence Corey, Fred Hutchinson Cancer Research Center, United States
15:15
HY01.02
Long acting injectable cabotegravir is safe and effective in preventing HIV infection in cisgender women: interim results from HPTN 084
Sinead Delany-Moretlwe, Wits RHI, South Africa
15:30
HY01.03
Panel discussion
Lawrence Corey, Fred Hutchinson Cancer Research Center, United States
Sinead Delany-Moretlwe, Wits RHI, South Africa
Connie Celum, University of Washington, United States
Jorge Sanchez, CITBM - Centro de Investigaciones Tecnológicas Biomédicas y Medioambientales, Peru
Nyaradzo Mgodi, University of Zimbabwe College of Health Sciences, Zimbabwe
Raphael Landovitz, UCLA Center for Clinical AIDS Research & Education, United States
Srilatha Edupuganti, Emory Vaccine Center, United States
Maureen Luba, AVAC, Malawi